Innovative Ansätze verbessern die Diagnostik und Therapie von Vaskulitiden, was den Patienten zugutekommt.
Key Points
This research aims to evaluate advancements in the diagnosis and treatment of vasculitis, particularly focusing on individualized therapies and imaging techniques.
Reviewed advancements in imaging techniques like high-resolution ultrasound and 18F-FDG-PET/CT.
Discussed the role of specific biomarkers in differentiating between types of vasculitis.
Evaluated new therapeutic approaches, including oral JAK1 inhibitors and monoclonal antibodies targeting IL-6 and IL-5.
High-resolution ultrasound and 18F-FDG-PET/CT are now preferred over temporal artery biopsy for diagnosing giant cell arteritis.
New therapies like upadacitinib and sarilumab have significantly improved remission rates with reduced steroid exposure.
Studies suggest that Rituximab is a viable alternative to Cyclophosphamide for several types of vasculitis.